BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37437827)

  • 1. PAK5 potentiates slug transactivation of N-cadherin to facilitate metastasis of renal cell carcinoma.
    Liu X; Pan YJ; Kang MJ; Jiang X; Guo ZY; Pei DS
    Cell Signal; 2023 Oct; 110():110803. PubMed ID: 37437827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
    Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
    Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
    Huang J; Yao X; Zhang J; Dong B; Chen Q; Xue W; Liu D; Huang Y
    Cancer Sci; 2013 Dec; 104(12):1609-17. PubMed ID: 24112779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
    Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
    J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG.
    Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H
    Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAK5-stabilized Smuc confers renal cell carcinoma metastasis.
    Huo FC; Zhu ZM; Du QY; Pei DS
    Clin Transl Med; 2021 Sep; 11(9):e559. PubMed ID: 34586742
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mukai M; Okada Y
    Lab Invest; 2011 Oct; 91(10):1443-58. PubMed ID: 21808237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
    Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
    J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.
    Han KS; Li N; Raven PA; Fazli L; Ettinger S; Hong SJ; Gleave ME; So AI
    Mol Cancer Ther; 2015 Apr; 14(4):1024-34. PubMed ID: 25657336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma.
    O'Mahony FC; Faratian D; Varley J; Nanda J; Theodoulou M; Riddick AC; Harrison DJ; Stewart GD
    PLoS One; 2012; 7(2):e31557. PubMed ID: 22363672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition.
    Han X; Piao L; Yuan X; Wang L; Liu Z; He X
    Int J Med Sci; 2019; 16(10):1404-1411. PubMed ID: 31692936
    [No Abstract]   [Full Text] [Related]  

  • 14. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
    Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
    Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRNDE mediates the viability and epithelial-mesenchymal transition of renal cell carcinoma via miR-136-5p.
    Zhang Y; Lan X; Wang Y; Liu C; Cui T
    J Recept Signal Transduct Res; 2021 Jun; 41(3):234-244. PubMed ID: 32808846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.
    Xin L; Zhao R; Lei J; Song J; Yu L; Gao R; Ha C; Ren Y; Liu X; Liu Y; Yao Z; Yang J
    FASEB J; 2019 Mar; 33(3):3795-3806. PubMed ID: 30509125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.